Why did my prescriber say they prefer long-acting Adderall XR and not a short-acting amphetamine?

A preference for long-acting Adderall XR over a short-acting amphetamine often tracks Canadian guidance rather than a personal quirk of one clinic. CAMH states that long-acting stimulants are generally preferred over short-acting products because of effect and adherence. On the CADDRA medication chart, Adderall XR is a first-line long-acting option for adults, listed around 12 hours with a 50/50 release profile, while short- and intermediate-acting stimulants are second-line. If the change is persistent, distressing, or affecting daily functioning, bring a brief timeline to the prescribing clinician rather than changing the dose independently. Related reading: https://www.fastreat.com/en/blogs/adhd-medication References: https://www.caddra.ca/wp-content/uploads/CADDRA_ADHD-Medication-Chart_May2026.pdf https://www.camh.ca/en/professionals/treating-conditions-and-disorders/adult-adhd/adult-adhd---treatment/adult-adhd---pharmacotherapy https://www.nice.org.uk/guidance/ng87/chapter/recommendations